Zhen-yu Guo
Beijing, 102488, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Efficacy of mangiferin, kaempferol, and diosgenin on models of depression: A systematic review and network meta-analysis of rodent studies.
Journal: European journal of pharmacology
Published: January 05, 2025
Mangiferin: A natural neuroprotective polyphenol with anti-inflammatory and anti-oxidant properties for depression.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: July 27, 2024
Corrigendum to "RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3ß and JNK signaling pathways in dopaminergic neuron-like cells" [Brain Res. Bull. 146 (2019) 228-236].
Journal: Brain research bulletin
Published: March 14, 2024
A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression.
Journal: European journal of clinical pharmacology
Published: May 04, 2023
Efficacy of Chinese herbal formula Kai-Xin-San on rodent models of depression: A systematic review and meta-analysis.
Journal: Journal of ethnopharmacology
Published: March 07, 2023
Association between variants of MTHFR genes and psychiatric disorders: A meta-analysis.
Journal: Frontiers in psychiatry
Published: June 23, 2022
Mangiferin, a natural glucoxilxanthone, inhibits mitochondrial dynamin-related protein 1 and relieves aberrant mitophagic proteins in mice model of Parkinson's disease.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 20, 2021
Efficacy of paeoniflorin on models of depression: A systematic review and meta-analysis of rodent studies.
Journal: Journal of ethnopharmacology
Published: October 14, 2021
Inhibition of dynamin-related protein 1 ameliorates the mitochondrial ultrastructure via PINK1 and Parkin in the mice model of Parkinson's disease.
Journal: European journal of pharmacology
Published: January 31, 2021
Bu-Yin-Qian-Zheng Formula Ameliorates MPP+-Induced Mitochondrial Dysfunction in Parkinson's Disease via Parkin.
Journal: Frontiers in pharmacology
Published: June 28, 2020
Da-Bu-Yin-Wan and Qian-Zheng-San Ameliorate Mitochondrial Dynamics in the Parkinson's Disease Cell Model Induced by MPP.
Journal: Frontiers in pharmacology
Published: October 26, 2018
RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3ß and JNK signaling pathways in dopaminergic neuron-like cells.
Journal: Brain research bulletin
Published: May 28, 2018
Last Updated: 09/26/2026